CIK 0001625101
- Non-accelerated filer
- Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465696597
- Phone
- +1 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- 4 Open-market buy Director bought 20,556 shares at $22.44 ($461,277)
- 4 Open-market buy Director bought 4,000 shares at an average $23.07 ($92,268)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 22,901 shares at $22.79 ($521,868)
- 4 Open-market buy 10% owner bought 2,000,000 shares at $15.02 ($30,040,000)
- 4 Open-market buy Director bought 29,775 shares at an average $13.36 ($397,670)
- 4 Open-market buy Director bought 3,835 shares at an average $12.30 ($47,170)
- 4 Open-market buy 10% owner bought 409,918 shares at an average $14.36 ($5,885,103)
- 4 Open-market buy Director bought 28,790 shares at an average $23.96 ($689,801)
- 4 Open-market buy 10% owner bought 277,450 shares at an average $23.14 ($6,419,318)
- 4 Grant or award CEO and President acquired 160,974 shares (grant or award)
- 4 Open-market buy 10% owner bought 83,928 shares at an average $26.86 ($2,254,330)
- 4 Derivatives Options or other derivatives
Page 10 of 12 · 231 filings